CAT# | CPM-1-0711 |
Sequence | YLLEILWRL |
Size | 100 test | Storage | 4 ̊C | Epitope Origin | EBV LMP1 YLL | MHC Restriction | HLA-A02_01 | Conjugate | PE |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
CPM-1-0727 | HLA-B_07_02 Flu HA 308 tetramer-IPSIQSRGL-PE labeled | Inquiry | ||
CPM-1-0052 | HLA-A_24_02 HBV pol tetramer-KYTSFPWLL-PE labeled | Inquiry | ||
CPM-1-0285 | HLA-A_02_01 MAGE-A10 tetramer-GLYDGMEHL-APC labeled | Inquiry | ||
CPM-1-0245 | HLA-B_07_02 AdV Hexon 114-124 tetramer-KPYSGTAYNAL-PE labeled | Inquiry | ||
CPM-1-0038 | HLA-A_11_01 EBV EBNA3B 416-424 tetramer-IVTDFSVIK-PE labeled | Inquiry |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
10-101-20 | Goserelin Acetate | 1269.43 | C59H84N18O14 | Inquiry |
10-101-59 | Liraglutide | 3751.2 | C172H265N43O51 | Inquiry |
R1574 | Octreotide | 1019.24 | C₄₉H₆₆N₁₀O₁₀S₂ | Inquiry |
10-101-139 | Myrcludex B | Inquiry | ||
10-101-285 | Teduglutide | 3752.08 | C164H252N44O55S | Inquiry |
R1847 | Sermaglutide | 4114 | C187H291N45O59 | Inquiry |
R1961 | Carbetocin | 988.2 | C45H69N11O12S | Inquiry |
Required fields are marked with *
×Required fields are marked with *
×* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
PM102 is a novel synthetic peptide that effectively reverses the anticoagulant effect of heparin. It can be used ...
Figure 1. Chemical structure of lysipressinLysipressin ([Lys8]-vasopressin) has been identified in the North Ame ...
Neurotransmitter Inhibitor Peptides Peptides used in topical anti-aging products have multiple applications. Gorouhi and Maib ...
Overview of the kinin system Kinins are peptide hormones that are formed as part of the kinin-kallikrein system (KKS). kinin ...
KAI-1455, a ε-protein kinase C activator in Phase I testing for the treatment of ischemia-induced reperfusion i ...